Recent transactions
Co-development Partnership
X
December 2025
Co-development agreement for the formulation and manufacturing of SeaBeLife's ophtalmic drug candidate
Fundraising
€1.5M in 2025
Developer of innovative immunotherapies designed to enhance antitumor immune responses
Research Partnership
X
November 2025
Research partnership focused on developing an exosome-based therapy targeting inflammatory liver diseases
Series A
€10M in 2025
Developer of exosome-based therapies for regenerative medicine applications
pre-Series A
€2M in 2025
Developer of innovative molecules to treat severe disease involving regulated necrosis
Series A
£8.7m in 2022
Designer of medical biomaterials based on collagen from marine sources
Series A
€6M in 2022
Designer of a 3D printed breast prosthesis for women who have undergone a mastectomy
​
Series A
€9M in 2018
Medtech company developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders